−NMDA R/+VDR pharmacological phenotype as a novel therapeutic target in relieving motor–cognitive impairments in Parkinsonism

References

• Agholme L, Lindström T, Kågedal K, et al. (2010). An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J Alzheimers Dis 20:1069–1082
   PubMed Web of Science ®Google Scholar
• Alcalay RN, Caccappolo E, Mejia-Santana H, et al. (2014). Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. JAMA Neurol 71:62–67
   Web of Science ®Google Scholar
• Barbiero JK, Santiago R, Tonin FS, et al. (2014). PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiat 53C:35–44
   Web of Science ®Google Scholar
• Benítez-King G, Domínguez-Alonso A, Ramírez-Rodrígue G. (2010a). Neurocytoskeletal protective effect of melatonin: importance for morphofunctional neuronal polarization. Open Neuroendocrinol J 3:105–111
   Google Scholar
• Benítez-King G, Domínguez-Alonso A, Ramírez-Rodrígue G. (2010b). Haloperidol cau' cytoskeletal collapse in N1E-115 cells through tau hyperphosphorylation induced by oxidative stress: implications for neurodevelopment. Eur J Pharmacol 644:24–31
   PubMed Web of Science ®Google Scholar
• Bertran-Gonzalez J, Håkansson K, Borgkvist A, et al. (2009). Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. Neuropsychopharmacology 34:1710–1720
   PubMed Web of Science ®Google Scholar
• Bishnoi M, Chopra K, Kulkarni SK. (2008). Activation of striatal inflammatory mediators and caspase-3 is central to haloperidol-induced orofacial dyskinesia. Eur J Pharmacol 590:241–245
   PubMed Web of Science ®Google Scholar
• Biundo R, Calabrese M, Weis L, et al. (2013). Anatomical correlates of cognitive functions in early Parkinson's disease patients. PLoS One 8:e64222
   PubMed Web of Science ®Google Scholar
• Björkblom B, Adilbayeva A, Maple-Grødem J, et al. (2013). Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity. J Biol Chem 288:22809–22820
   PubMed Web of Science ®Google Scholar
• Blandini F, Porter RH, Greenamyre JT. (1996). Glutamate and Parkinson's disease. Mol Neurobiol 12:73–94
   PubMed Web of Science ®Google Scholar
• Bosch-Bouju C, Hyland BI, Parr-Brownlie LC. (2013). Motor thalamus integration of cortical, cerebellar and basal ganglia information: implications for normal and parkinsonian conditions. Front Comput Neurosci 7:163
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. (2000). Pathoanatomy of Parkinson's disease. J Neurol 247:II3–II0
   PubMed Web of Science ®Google Scholar
• Braak H, Rüb U, Braak E. (2000). Neuroanatomy of Parkinson disease. Changes in the neuronal cytoskeleton of a few disease-susceptible types of neurons lead to progressive destruction of circumscribed areas in the limbic and motor systems. Nervenarzt 71:459–469
   PubMed Web of Science ®Google Scholar
• Busceti CL, Biagioni F, Calierno MT, et al. (2013). Novel aspects of striatal plasticity associated with long-term levo-dopa administration. Arch Ital Biol 151:192–202
   PubMed Web of Science ®Google Scholar
• Byron KY, Bitanihirwe BK, Tsung-Ung WW. (2010). Oxidative Stress In Schizophrenia: An Integrated Approach. Neurosci Biobehav Rev 35:878–893
   PubMed Web of Science ®Google Scholar
• Camu W, Tremblier B, Plassot C, et al. (2014). Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis. Neurobiol Aging 35:1198–1205
   PubMed Web of Science ®Google Scholar
• Castellano O, Martínez-Martí L, Gómez-Fernández L. (1998). Nerve growth factor and diabetic neuropathy. Rev Neurol 26:1032–1039
   PubMed Web of Science ®Google Scholar
• Cazorla M, de Carvalho FD, Chohan MO, et al. (2014). Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry. Neuron 81:153–164
   Google Scholar
• Chen T, Yang YF, Luo P, et al. (2013). Homer1 knockdown protects dopamine neurons through regulating calcium homeostasis in an in vitro model of Parkinson's disease. Cell Signal 25:2863–2870
   PubMed Web of Science ®Google Scholar
• Chou JS, Chen CY, Chen YL, et al. (2014). (G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse. Neurobiol Dis 68:190–199
   Google Scholar
• Clelland JD, Read LL, Drouet V, et al. (2014). Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association. Schizophr Res 156:15–22
   PubMed Web of Science ®Google Scholar
• Cui X, Pelekanos M, Liu PY, et al. (2013). The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain. Neuroscience 236:77–87
   PubMed Web of Science ®Google Scholar
• Deepak CD, Gabriel B, Rebecca B, et al. (2008). Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humans. Psychopharmacology (Berl) 198:587–603
   PubMed Web of Science ®Google Scholar
• Dehay B, Martinez-Vicente M, Ramirez A, et al. (2012). Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove. Autophagy 8:1389–1391
   PubMed Web of Science ®Google Scholar
• Delotterie D, Ruiz G, Brocard J, et al. (2010). Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice. Psychopharmacology (Berl) 208:131–141
   PubMed Web of Science ®Google Scholar
• Drago A, Giegling I, Schäfer M, et al. (2013). AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment. Eur Neuropsychopharmacol 23:887–894
   PubMed Web of Science ®Google Scholar
• Engel T, Goñi-Oliver P, Gomez-Ramos P, et al. (2008). Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3beta. Neuroscience 157:772–780
   PubMed Web of Science ®Google Scholar
• Espinoza S, Salahpour A, Masri B, et al. (2011). Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol Pharmacol 80:416–425
   PubMed Web of Science ®Google Scholar
• Eyles DW, Smith S, Kinobe R, et al. (2005). Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29:21–30
   PubMed Web of Science ®Google Scholar
• Faucheux BA, Martin ME, Beaumont C, et al. (2003). Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. J Neurochem 86:1142–1148
   PubMed Web of Science ®Google Scholar
• Ferrer I, López-Gonzalez I, Carmona M, et al. (2012). Neurochemistry and the non-motor aspects of PD. Neurobiol Dis 46:508–526
   PubMed Web of Science ®Google Scholar
• Fuglestad AJ, Fink BA, Eckerle JK, et al. (2013). Inadequate intake of nutrients essential for neurodevelopment in children with fetal alcohol spectrum disorders (FASD). Neurotoxicol Teratol 39:128–132
   PubMed Web of Science ®Google Scholar
• Harms LR, Burne TH, Eyles DW, McGrath JJ. (2011). Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab 25:657–669
   PubMed Web of Science ®Google Scholar
• Hasbi A, Fan T, Alijaniaram M, et al. (2009). Calcium signaling cascade links dopamine D1–D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci USA 106:21377–21382
   PubMed Web of Science ®Google Scholar
• Höglinger GU, Féger J, Prigent A, et al. (2003). Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem 84:491–502
   PubMed Web of Science ®Google Scholar
• Hou Z, Lei H, Hong S, et al. (2010). Functional changes in the frontal cortex in Parkinson's disease using a rat model. J Clin Neurosci 17:628–633
   PubMed Web of Science ®Google Scholar
• Hurley MJ, Dexter DT. (2012). Voltage-gated calcium channels and Parkinson's disease. Pharmacol Ther 133:324–333
   PubMed Web of Science ®Google Scholar
• Ibáñez-Sandoval O, Carrillo-Reid L, Galarraga E, et al. (2007). Bursting in substantia nigra pars reticulata neurons in vitro: possible relevance for Parkinson disease. J Neurophysiol 98:2311–2323
   PubMed Web of Science ®Google Scholar
• Konieczny J, Jantas D, Lenda T, et al. (2014). Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's disease. Neurotox Res 26:255–273
   Google Scholar
• Li Z, Wang Y, Xie Y, et al. (2011). Protective effects of exogenous hydrogen sulfide on neurons of hippocampus in a rat model of brain ischemia. Neurochem. Res 36:1840–1849
   PubMed Web of Science ®Google Scholar
• Liu Q, Trotter J, Zhang J, et al. (2010). Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. J Neurosci 30:17068–17078
   PubMed Web of Science ®Google Scholar
• Liu Y, Li YW, Tang YL, et al. (2013). Vitamin D: preventive and therapeutic potential in Parkinson's disease. Curr Drug Metab 14:989–993
   PubMed Web of Science ®Google Scholar
• Lu'o'ng KV, Nguyên LT. (2011). The beneficial role of vitamin D in Alzheimer's disease. Am J Alzheimers Dis Other Demen 26:511–520
   PubMed Web of Science ®Google Scholar
• Makariou SE, Michel P, Tzoufi MS, et al. (2014). Vitamin D and stroke: promise for prevention and better outcome. Curr Vasc Pharmacol 12:117–124
   PubMed Web of Science ®Google Scholar
• Nakahashi O, Yamamoto H, Tanaka S, et al. (2014). Short-term dietary phosphate restriction up-regulates ileal fibroblast growth factor 15 gene expression in mice. J Clin Biochem Nutr 54:102–108
   PubMed Web of Science ®Google Scholar
• Nissou M-F, Brocard J, El Atifi M, et al. (2013). The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases. J Alzheimers Dis 35:553–564
   PubMed Web of Science ®Google Scholar
• Ogundele OM, Okunnuga AA, Fabiyi TD, et al. (2014). NMDA receptor inhibition and potentiation affects cellular process formation in melanocytes; a model for synaptic denervation in Parkinsonism. Metabol Brain Disease 29:541–555
   PubMed Web of Science ®Google Scholar
• Orme RP, Bhangal MS, Fricker RA. (2013). Calcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression. PLoS One 8:e62040
   PubMed Web of Science ®Google Scholar
• Osuntokun BO. (1981). Cassava diet, chronic cyanide intoxication and neuropathy in the Nigerian Africans. World Rev Nutr Diet 36:141–173
   PubMedGoogle Scholar
• Patil KS, Basak I, Lee S, et al. (2014). PARK13 regulates PINK1 and subcellular relocation patterns under oxidative stress in neurons. J Neurosci Res 92:1167–1177
   Google Scholar
• Petersen MS, Bech S, Christiansen DH, et al. (2014). The role of vitamin D levels and vitamin D receptor polymorphism on Parkinson's disease in the Faroe Islands. Neurosci Lett 561:74–79
   PubMed Web of Science ®Google Scholar
• Peterson AL, Murchison C, Zabetian C, et al. (2013). Memory, mood, and vitamin d in persons with Parkinson's disease. J Parkinsons Dis 3:547–555
   PubMedGoogle Scholar
• Peterson AL. (2014). A review of vitamin D and Parkinson's disease. Maturitas 78:40–44. doi:10.1016/j.maturitas.2014.02.012
   PubMed Web of Science ®Google Scholar
• Picillo M, Erro R, Amboni M, et al. (2014). Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients. Parkinsonism Relat Disord 20:850–854
   Google Scholar
• Plum S, Helling S, Theiss C, et al. (2013). Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis. J Proteomics 94:202–206
   PubMed Web of Science ®Google Scholar
• Puri BK. (2014). Neurological and neuroimaging signs of reversible parkinsonism associated with manganese exposure. Neurol India 62:1–2
   PubMed Web of Science ®Google Scholar
• Reavill C, Kettle A, Holland V, et al. (1999). Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist. Br J Pharmacol 126:572–574
   PubMed Web of Science ®Google Scholar
• Ricciardi L, Bloem BR, Snijders AH, et al. (2014). Freezing of gait in Parkinson's disease: the paradoxical interplay between gait and cognition. Parkinsonism Relat Disord 20:824–829
   Google Scholar
• Smolders J, Moen SM, Damoiseaux J, et al. (2011). Vitamin D in the healthy and inflamed central nervous system: access and function. J Neurol Sci 311:37–43
   PubMed Web of Science ®Google Scholar
• Sugiyama A, Sun J. (2014). Immunochemical detection of lipid hydroperoxide- and aldehyde-modified proteins in diseases. Subcell Biochem 77:115–125
   PubMedGoogle Scholar
• Sühs KW, Fairless R, Williams SK, et al. (2014). N-methyl-d-aspartate receptor blockade is neuroprotective in experimental autoimmune optic neuritis. J Neuropathol Exp Neurol 73:507–518
   PubMed Web of Science ®Google Scholar
• Villalba RM, Smith Y. (2010). Striatal spine plasticity in Parkinson's disease. Front Neuroanat 4:133
   PubMedGoogle Scholar
• Voronkov DN, Khudoerkov RM, Dovedova EL. (2013). Changes in neuroglial interactions in the cerebral nigrostriatal structures in a model of dopamine system dysfunction. Zh Nevrol Psikhiatr Im S S Korsakova 113:47–51
   PubMedGoogle Scholar
• Walker RH, Davies G, Koch RJ, et al. (2010). Effects of zona incerta lesions on striatal neurochemistry and behavioral asymmetry in 6-hydroxydopamine-lesioned rats. J Neurosci Res 88:2964–2975
   PubMed Web of Science ®Google Scholar
• Wöbke TK, von Knethen A, Steinhilber D, Sorg BL. (2013). CD69 is a TGF-β/1α,25-dihydroxyvitamin D3 target gene in monocytes. PLoS One 8:e64635
   PubMed Web of Science ®Google Scholar
• Zhang YM, Wang CY, Zheng FC, et al. (2012). Effects of N-n-butyl haloperidol iodide on the rat myocardial sarcoplasmic reticulum Ca(2+)-ATPase during ischemia/reperfusion. Biochem Biophys Res Commun 425:426–430
   PubMed Web of Science ®Google Scholar
• Zhu XY, Pan TH, Ondo WG, et al. (2014). Effects of deep brain stimulation in relatively young-onset multiple system atrophy Parkinsonism. J Neurol Sci 342:42–44
   Google Scholar